Zhou XJ - Search Results

1

Antiemetic activity of megestrol acetate in patients receiving chemotherapy.

Zang J, Hou M, Gou HF, Qiu M, Wang J, Zhou XJ, Luo de Y, Yang Y, Jiang M, Cao D, Bi F, Xu F, Shen Y, Yi C. Zang J, et al. Among authors: zhou xj. Support Care Cancer. 2011 May;19(5):667-73. doi: 10.1007/s00520-010-0886-x. Epub 2010 Apr 26. Support Care Cancer. 2011. PMID: 20419494 Clinical Trial.

2

Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.

Gong Y, Ren L, Zhou L, Zhu J, Huang M, Zhou X, Wang J, Lu Y, Hou M, Wei Y. Gong Y, et al. Cancer Chemother Pharmacol. 2009 Jul;64(2):327-33. doi: 10.1007/s00280-008-0874-8. Epub 2008 Dec 2. Cancer Chemother Pharmacol. 2009. PMID: 19048253 Clinical Trial.

3

Evaluation of positioning accuracy of four different immobilizations using cone-beam CT in radiotherapy of non-small-cell lung cancer.

Wang J, Zhong R, Bai S, Lu Y, Xu Q, Zhou XJ, Xu F. Wang J, et al. Among authors: zhou xj. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1274-81. doi: 10.1016/j.ijrobp.2009.09.049. Epub 2010 Apr 17. Int J Radiat Oncol Biol Phys. 2010. PMID: 20400243

4

Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.

Zhong X, Luo G, Zhou X, Luo W, Wu X, Zhong R, Wang Y, Xu F, Wang J. Zhong X, et al. Thorac Cancer. 2016 Jan;7(1):50-60. doi: 10.1111/1759-7714.12274. Epub 2015 May 19. Thorac Cancer. 2016. PMID: 26816539 Free PMC article.

5

Neutrophil-lymphocyte ratio as a prognostic marker for chemotherapy in advanced lung cancer.

Liu ZL, Zeng TT, Zhou XJ, Ren YN, Zhang L, Zhang XX, Ding ZY. Liu ZL, et al. Among authors: zhou xj. Int J Biol Markers. 2016 Dec 23;31(4):e395-e401. doi: 10.5301/jbm.5000222. Int J Biol Markers. 2016. PMID: 27416842 Free article.

6

Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?

Tian X, Zhang X, Yu M, Lu Y, Ding Z, Huang M, Peng F, Ren L, Wang J, Wang Y, Xu Y, Zhu J, Zhou L, Zhou X, Deng M, Tang X, Gong Y. Tian X, et al. Int J Clin Oncol. 2018 Apr;23(2):258-265. doi: 10.1007/s10147-017-1206-y. Epub 2017 Nov 4. Int J Clin Oncol. 2018. PMID: 29103151

7

Continuation of Tyrosine Kinase Inhibitor is Associated with Survival Benefit in NSCLC Patients with Exon 19 Deletion after Solitary Progression.

Na F, Zhang J, Deng L, Zhou X, Zhou L, Zou B, Yu M, Li Y, Xue J, Liu Y. Na F, et al. J Cancer. 2017 Oct 12;8(18):3682-3688. doi: 10.7150/jca.20017. eCollection 2017. J Cancer. 2017. PMID: 29151955 Free PMC article.

8

Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.

Zhou Y, Yan T, Zhou X, Cao P, Luo C, Zhou L, Xu Y, Liu Y, Xue J, Wang J, Wang Y, Lu Y, Liang B, Gong Y. Zhou Y, et al. Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11. Strahlenther Onkol. 2020. PMID: 31828393

9

Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?

Zou B, Tu Y, Liao D, Xu Y, Wang J, Huang M, Ren L, Zhu J, Gong Y, Liu Y, Zhou L, Zhou X, Peng F, Lu Y. Zou B, et al. Thorac Cancer. 2020 Mar;11(3):631-639. doi: 10.1111/1759-7714.13307. Epub 2020 Jan 14. Thorac Cancer. 2020. PMID: 31943824 Free PMC article.

10

Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.

Zhou X, Zhou L, Yao Z, Huang M, Gong Y, Zou B, Zhu J, Liu Y, Peng F, Zhang Y, Yu M, Li Y, Na F, Wu Y, Kang K, Xiu W, Zhang X, Zhou L, Xu Y, Wang J, Wang Y, Yang X, Wu Y, Li R, Zhang Y, Yang Z, Zhou Z, Bai J, Yi X, Tong R, Yin L, Chen C, Niedermann G, Lu Y, Xue J. Zhou X, et al. Clin Cancer Res. 2023 Oct 13;29(20):4098-4108. doi: 10.1158/1078-0432.CCR-23-0315. Clin Cancer Res. 2023. PMID: 37581611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,260 results

Search Page